October 2, 2026
Twine Saver, Q3 2026: business formation and corporate strategy
New business applications peaked in July and cooled in August. Companies reshaped themselves through carve-outs, roll-ups, reverse mergers and acquisitions of AI and data businesses, while the cost of capital rose.
Intertwine Partners4 min read

Intertwine Associates helps organizations form, grow and run well, and Intertwine Digital builds the software that scientific businesses run on. This review looks at how businesses were formed and reshaped from July 1 to September 30, 2026, from Census Bureau data, the Federal Reserve, and companies' own announcements and SEC filings.
Business formation: a July peak
The Census Bureau's Business Formation Statistics (seasonally adjusted, as first published):
| Data month | Business applications | High-propensity applications | Projected new employers within four quarters |
|---|---|---|---|
| June | 531,423 (+1.1%) | 149,714 (+1.9%) | 29,741 (+0.7%) |
| July | 578,926 (+8.1%) | 151,857 (+1.4%) | 29,959 (+0.7%) |
| August | 531,728 (-7.8%) | 145,387 (-4.1%) | 28,501 (-4.6%) |
High-propensity applications are those the Census Bureau judges most likely to become businesses with payroll. Applications in professional, scientific and technical services, the sector consulting and research firms belong to, numbered 80,691 in August.
Our read: formation remained high by historical standards, but the August pull-back, most visible in the applications most likely to hire, came as borrowing costs rose. September's figures are due October 14.
Two strands of new business, indexed
Business applications and high-propensity applications (those most likely to become employers), each set to 100 in August 2025. All applications rose faster, peaked in July and fell back; the likely employers moved far less. Seasonally adjusted, as currently revised.
Business applications, change on the month
Seasonally adjusted, as currently revised. July's 8.1 percent jump was the largest in the year; August gave most of it back.
The cost of capital
The Federal Reserve held its target range at 3-1/2 to 3-3/4 percent on July 29, with three members preferring an increase. On September 16 it raised the range to 3-3/4 to 4 percent, unanimously, to support a timelier return to its 2 percent inflation goal. For companies that are not yet profitable, the quarter ended with money costing more than it did at the start.
Strategy: how companies reshaped themselves
Carve-outs.
- Progress Software completed its purchase of substantially all of Domo's AI and data platform business for $400 million on September 22, a carve-out from a public company.
- Standard BioTools moved to sell its mass cytometry business ahead of its merger with Treeline Biosciences, then changed buyers on September 30.
Roll-ups.
- Altaris's agreement to take Simulations Plus private at $18.50 a share cleared its antitrust review in August. Altaris plans to combine the scientific modeling software company with Chemical Computing Group, another molecular design software business it owns.
- Private equity also agreed to take the contract manufacturer Lifecore Biomedical private.
Reverse mergers as a financing route. Slate Medicines will merge into Fulcrum Therapeutics, raising $245 million privately alongside. Slate's holders will own 95 percent of the combined public company, and Fulcrum will pay a dividend of about $270 million to its existing holders.
Buying AI and data capability.
- AMD agreed to acquire World Labs in an all-stock deal valued at about $8.2 billion.
What it means
Our read, not advice:
- For new companies. The best time to set up clean structures is at formation: separable IP, clear data rights and contracts that can be assigned. It makes a later carve-out, licence or reverse merger simpler.
- For established companies. Carve-outs and roll-ups were the quarter's tools for focus and scale. Businesses with a unit outside their core have more ways to sell or combine it than a few years ago.
- For scientific software. Buyers are paying for data, models and workflow software that sit close to scientific decisions. Roll-ups that combine complementary tools, such as Simulations Plus and Chemical Computing Group, are one way that market is consolidating.
- For planning. With rates rising, financing plans need more room for delay and more than one route.
What we are watching next quarter
- September business formation data on October 14.
- Whether rising rates slow carve-outs and private equity roll-ups.
- How AI and data acquisitions are integrated into larger platforms.
Sources are linked above: the U.S. Census Bureau, the Federal Reserve, and company announcements and SEC filings. This report is a general summary of trends, prepared by Intertwine Partners solely from publicly available information, and offered for general interest. It is not investment, legal, tax or regulatory advice, not a recommendation about any security, and not an offer or solicitation. The mention of any company does not imply endorsement or any relationship. See the full terms in our Legal Notices, including our independence and conflicts of interest statement. Company and product names are the property of their owners.
See Related

October 2, 20264 min read
Twine Saver, Q3 2026: the quarter in company building
Fewer but larger life science deals, contingent pay in nearly every one of them, a selective IPO window, a Federal Reserve that turned to tightening, and business formation that peaked in July. A look back at July through September 2026.
Intertwine Partners
Twine SaverQuarterly reviewMarkets
Read More
October 2, 20265 min read
Twine Saver, Q3 2026: life science deals and public markets
The quarter's acquisitions, licences and IPOs in biotech, pharma, medtech and contract manufacturing, and the deal structures that ran through them: contingent value rights, asset-only purchases and strategic investors in IPOs.
Intertwine Partners
Twine SaverQuarterly reviewLife sciencesMarkets
Read More
July 10, 20253 min read
Launch announcement: Twine Time
Our identity, in motion. The INTERTWINE wordmark, the marks of our three companies and the one thread that joins them, built from the start to be clear and to work hard.
Intertwine Team
LaunchAnnouncementPortfolioOperational excellence
Read More